Cargando…
Topical Administration of a Novel Acetylated Tetrapeptide Suppresses Vascular Permeability and Immune Responses and Alleviates Atopic Dermatitis in a Murine Model
Although the pathogenesis of atopic dermatitis (AD) remains to be fully deciphered, skin barrier abnormality and immune dysregulation are known to be involved. Recently, the vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR) system has also been implicated in the pathogenesis of this mu...
Autores principales: | Sung, Bokyung, Baek, Yi-Yong, Kim, Young-Myeong, You, Ji Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658216/ https://www.ncbi.nlm.nih.gov/pubmed/36362286 http://dx.doi.org/10.3390/ijms232113498 |
Ejemplares similares
-
Therapeutic Efficacy of a Novel Acetylated Tetrapeptide in Animal Models of Age-Related Macular Degeneration
por: Koo, Hye Cheong, et al.
Publicado: (2021) -
Arg-Leu-Tyr-Glu tetrapeptide inhibits tumor progression by suppressing angiogenesis and vascular permeability via VEGF receptor-2 antagonism
por: Baek, Yi-Yong, et al.
Publicado: (2016) -
Management of Atopic Dermatitis Via Oral and Topical Administration of Herbs in Murine Model: A Systematic Review
por: Mohd Kasim, Vivi Nur Khalieda, et al.
Publicado: (2022) -
Topical bismuth oxide-manganese composite nanospheres alleviate atopic dermatitis-like inflammation
por: Li, Mengjie, et al.
Publicado: (2023) -
Repurposing Belinostat for Alleviation of Atopic Dermatitis
por: Quah, Shan, et al.
Publicado: (2021)